Artemis Therapeutics, Inc. (ATMS) financial statements (2021 and earlier)

Company profile

Business Address 18 EAST 16TH STREET
NEW YORK, NY 10003
State of Incorp. DE
Fiscal Year End December 31
SIC 289 - Miscellaneous Chemical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments127525907
Cash and cash equivalents127525907
Other undisclosed current assets1020205865
Total current assets:112227583972
Noncurrent Assets
TOTAL ASSETS:112227583972
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2461571615358
Accrued liabilities2461571615358
Derivative instruments and hedges, liabilities  163  
Due to related parties110    
Total current liabilities:3561573245358
Noncurrent Liabilities
Liabilities, other than long-term debt 103   
Due to related parties 103   
Other undisclosed noncurrent liabilities   428 
Total noncurrent liabilities: 103 428 
Total liabilities:35626032448158
Stockholders' equity
Stockholders' equity attributable to parent(345)(238)(297)102914
Common stock525252522,887
Additional paid in capital1,9211,9071,5711,457(1,709)
Accumulated deficit(2,318)(2,197)(1,920)(1,407)(264)
Total stockholders' equity:(345)(238)(297)102914
TOTAL LIABILITIES AND EQUITY:112227583972

Income statement (P&L) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Operating expenses(167)(168)(772)(1,039) 
Operating loss:(167)(168)(772)(1,039) 
Nonoperating income (expense)(7)(6)259(104) 
Investment income, nonoperating (6)259  
Other nonoperating expense   (104) 
Loss from continuing operations before income taxes:(174)(174)(513)(1,143) 
Income tax benefit5353   
Net loss attributable to parent:(121)(121)(513)(1,143) 
Preferred stock dividends and other adjustments(18)(18)(77)(171) 
Other undisclosed net income available to common stockholders, basic3636154342 
Net loss available to common stockholders, diluted:(103)(103)(436)(972) 

Comprehensive Income ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(121)(121)(513)(1,143) 
Comprehensive loss, net of tax, attributable to parent:(121)(121)(513)(1,143) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: